Welcome Guest | |
Live Chat
Call Back
Submit Your Sourcing Requirement
Advanced Search Filtersdown arrow

Kayson Pharmaceuticals

Company Summary:

  • Since 1990
  • 51-75 Employees
  • Turnover 1,000,000.00 USD per year
  • 60% turn over from existing products
  • 60 year(s) of Export Experience
  • Limited Company

Additional Contacts:

Export Department
special pharmaceuticals
Phone: +00 - 9947 - 8401/+237 - 99478401
Fax: +1 -

Company Address:

Canada, 418
Web Page Link: http://www.toboc.com/specialpharmaceuticals

"Kayson pharmaceuticals" is listed under following Categories:

About Us

Actavis provides generic pharmaceutical products to the Canadian market through its Cobalt Pharmaceuticals business. In 2011, the Company had the highest growth rate in prescriptions in the Canadian market and launched 10 products including Clopidogrel, Levonorgestrel, Latanoprost and Candesartan. Additionally, the Company filed 20 applications during the year and launched a new sales organization in Quebec, which accounts for approximately 22% of the Canadian market.
In addition, Actavis is engaged in the marketing, sale and distribution of branded pharmaceutical products within the Canadian market and overseas under the name Actavis Specialty Pharmaceuticals Co. We are focused on delivering innovative products that address key therape`utic categories in Urology and Women's Health.

Export Criteria

Principal Export Regions: Central America
Preferred Languages: English
Delay of Payment: Immediate
Modes of Payment: Bank Wire Transfer (swift)
Incoterms: Free on board
Minimum Order Amt: Any Amount
Avg. Production time from a Firm Order: Any Delivery Time
Shipping Port: duala
Preferred Currencies: Euros
UK Pounds
US Dollars
Monthly Production Capacity
- in US Dollars: 2356
- in Number of Items: 6542
- in Volume: 653256